SCHEMBL25812222

SCHEMBL25812222

CN(c1c2ccccc2cc2ccccc12)c1c2ccccc2cc2ccccc12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.44
HSD17B10 Q99714 4/20 0.44
HIF1A Q16665 1/20 0.44
CYP1B1 Q16678 1/20 0.44
CYP1A2 P05177 5/20 0.43
CYP2A6 P11509 2/20 0.43
HTR2A P28223 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
HPGD P15428 2/20 0.42
KDM4E B2RXH2 3/20 0.41
CYP2C19 P33261 2/20 0.41
MEN1 O00255 1/20 0.41
GLA P06280 1/20 0.41
KMT2A Q03164 1/20 0.41
CYP3A4 P08684 1/20 0.40
ERBB2 P04626 1/20 0.40
FYN P06241 1/20 0.40
MAOA P21397 1/20 0.40
ACHE P22303 1/20 0.40
AHR P35869 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13899999 0.89 L3MBTL1 (0.40) ALDH1A1HSD17B10HIF1ACYP1B1CYP1A2
SCHEMBL12048718 0.87 PDE5A (0.42) ALDH1A1HSD17B10HIF1ACYP1B1CYP1A2
SCHEMBL9821944 0.85 ALDH1A1 (0.44) ALDH1A1HSD17B10HIF1ACYP1B1CYP1A2
SCHEMBL12258278 0.82 CYP1A2 (0.42) ALDH1A1HSD17B10CYP1A2CYP2A6L3MBTL1
SCHEMBL12047742 0.80 ALDH1A1 (0.39) ALDH1A1HSD17B10CYP1A2L3MBTL1HPGD
SCHEMBL18799917 0.80 CES2 (0.40) ALDH1A1HSD17B10HIF1ACYP1B1CYP1A2
SCHEMBL13900021 0.79 TERT (0.53) ALDH1A1HSD17B10HIF1ACYP1B1CYP1A2
SCHEMBL12566478 0.78 ALDH1A1 (0.48) ALDH1A1HSD17B10HIF1ACYP1B1CYP1A2
SCHEMBL12048257 0.78 CYP1A2 (0.39) ALDH1A1HSD17B10CYP1A2CYP2A6L3MBTL1
SCHEMBL20384973 0.76 CYP1A2 (0.31) ALDH1A1HSD17B10HIF1ACYP1B1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11691991-B2 Compound, a display panel and a display device Shanghai Tianma AM-OLED Co., Ltd. (CN) 2023-07-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11691991-B2 Compound, a display panel and a display device BROX, BRSK1, BRSK2 ALDH1A1 711/4885HSD17B10 1387/4885HIF1A 4584/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.